BioSante Pharmaceuticals, Inc. (BPAX)

[nutsyprofessor]

LEERINK SWANN REPORT - keep this on top!

""We believe that pivotal BLOOM efficacy data in November has been de-risked by positive P&G Intrinsa (testosterone patch) data. Based on our analysis of eight successful placebo controlled Intrinsa trials, transdermal testosterone appears to be efficacious in treating HSDD, and positive BLOOM data is primarily a function of trial design and execution, both of which we believe BPAX has addressed well.""

""We believe the addressable postmenopausal HSDD patient population is 6.5MM women in the U.S., which represents an unmet medical need according to the FDA. We base our expectations on conversations with key thought leaders and analysis of a large body of existing evidence demonstrating safety/efficacy of topical testosterone therapy in treating HSDD.""

""In particular, extensive Intrinsa (PG) clinical trial data suggests to us that BPAX has a high probability of showing long-term safety for LibiGel and may even demonstrate superiority over placebo in outcomes unrelated to HSDD, such as cardio protection, bone density, or cognition in a best case scenario. We believe BPAX has a strong management team that was instrumental in developing Androgel for the male hypogonadism market, which now has U.S. sales of over $1Bn annually, and succeeded in obtaining approval for Elestrin (topical estradiol gel) in a difficult regulatory environment.""

http://www.filedump.net/dumped/bpax13100...

Note that it's all about HSDD women with LibiGel! The initial top-line results provided by BioSante include HSDD and non-FSD women! The subsequent analysis being done by BioSante will remove the non-FSD women and the analysis will show efficacy. There are countless clinical trials coming before the BLOOM trials that have already shown/proven that testosterone works for this indication.

Don't let the temporary stock price dips scare you out of your shares! I guarantee you that those in the know are accumulating the shares that YOU lose by selling in fear!!!

Stick it out people and give BioSante some time to review the data more closely and let's see what they come back with on the next LibiGel update...I can't wait!!!